Hepatoblastoma is a rare tumour affecting about 1/100 000 children under the age of 15 years.1 Polyposis coli is another uncommon condition with an estimated incidence of approximately 1/8000 births. 2 We have previously reported a possible association between hepatoblastoma and polyposis coli.3 In the United Kingdom one case of polyposis coli occurring in the mother of a child with hepatoblastoma would be expected in about 1000 years. We describe five such cases occurring during a period of 50 years.
Patients and methods
Three of the five children were identified during a review of the records of 113 cases of hepatoblastoma registered with the Childhood Cancer Research Group during the period [1962] [1963] [1964] [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] . A further two 'anecdotal' cases were notified to us by clinicians rather than to just the mother it is more appropriate to make comparisons with the chance of polyposis coli occurring in either parent-that is 1/4000. Our findings are then that polyposis coli occurs 100 times more frequently among the parents of children with hepatoblastoma than among parents generally and that such an association would be expected to occur in Britain only once every 500 years).
The probability that any three mothers among a group of 113 have a disease with a frequency as low as that of polyposis coli, is about 1/2 million; the probability that either the mother or father will be affected in three cases is about 1/250 000. This does not mean, however, that we can state that the association is statistically significant at one of these levels. It is not possible to carry out a valid statistical test since we did not set out to analyse our data for any specific association; in calculating a significant level we should take into account the fact that even if there were no real disease association with hepatoblastoma, we might have observed any one of a large number of possible disease associations purely by chance. Unfortunately, there seems to be no satisfactory way of quantifying this in the present instance. We suggest, however, particularly in view of the two additional 'anecdotal' cases reported here and the fact that children whose mothers had polyposis coli seem to have a particularly good prognosis, that the most reasonable explanation of our findings is that there is a true association between hepatoblastoma and maternal polyposis coli. Various conditions are known to occur in association with polyposis coli. In 1962 Gardner12 described a group of polyposis coli patients with a cluster of benign extra colonic manifestations including osteomas of the cranium and mandible with overlying fibromata, abnormal dentition, sebaceous or epidermoid cysts on the back, and, occasionally, mesenteric fibromatosis. Other extracolonic neoplasms that have been described in patients with Gardner Gardner has reported a consistent heteromorphism of chromosome no 2 (2q 21-3) in 17 patients with multiple adenomas of the colorectum.20 Therefore, in our initial report of the association between hepatoblastoma and polyposis coli,3 we considered it possible that a chromosomal abnormality, such as a deletion, might be found in some patients with hepatoblastoma, particularly in those children who had a family history of polyposis coli. As yet, however, we have not succeeded in identifying any structural chromosomal abnormality in the three families that have been studied. All five of the children had well or moderately well differentiated tumours; which were completely resectable. Three of the five children are considered to have died from complications of surgery rather than recurrent hepatoblastoma. As polyposis coli is inherited as an autosomal dominant condition, the two surviving children with hepatoblastoma have a 1/2 chance of developing polyposis coli and will need to be screened regularly.
In summary, the present report describes five children with hepatoblastoma all of whom have a history of polyposis coli affecting the mother. In four of the children, one or more of the maternal relatives is also known to have had polyposis coli. One of the five children, case 5, is believed to have been included in a previous report describing the outcome of children with hepatic tumours.9 The additional four cases thus brings the number of reported cases of hepatoblastoma occurring in children with a family history of polyposis coli to a total of 7. For reasons explained above, we consider that the association of these two conditions is unlikely to have occurred by chance. 
